SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (“Kratos”) (NASDAQ: KTOS), a Technology, Hardware, Products, System and Software Company addressing the Defense, National Security and Commercial Markets, today announced that it intends to offer for sale $1,000,000,000 of shares of its common stock in an underwritten offering pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). The underwriters will have a 3 ...

assets—5,796121,404Deferred income tax benefit(1,364)(936)(801)Loss on disposal of equipment—844842Non-cash lease expense30,08228,09528,313Non-cash in-process research and development—19,7969,182Accretion of discount on marketable securities(3,390)——Other non-cash activity2,0641,2243,194Changes in operating assets and liabilities:Accounts receivable ($357, $156 and $816 from related parties)(1,473)(4,725)50,068Prepaid expenses and other current assets(5,247)10,08510,473Operating lease right-of-use assets3,8 ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ready Capital Corporation (NYSE: RC) (the “Company”) today announced the appointment of Dominick Scali as Chief Credit Officer of the Company and Co-President of ReadyCap Commercial, LLC, the Company’s commercial real estate lending business. Mr. Scali has been a Managing Director and Co-Head of Bridge Lending with the Company since 2015. Prior to that, he was head of credit and underwriting for Doral Bank’s national bridge lending platform and held positions in c ...

Core Viewpoint - Tevogen Bio Holdings Inc. has signed a non-exclusive, non-binding Letter of Intent to evaluate a potential acquisition of Sciometrix Inc., which would lead to Tevogen holding a majority voting interest in Sciometrix if completed [1][2]. Group 1: Potential Transaction - The transaction aims to enhance Tevogen's capabilities and transition it into a revenue-generating healthcare enterprise by integrating Sciometrix's digital care management platform, Clinicus, and remote patient monitoring technologies with Tevogen.AI [2][11]. - Sciometrix has achieved significant milestones, becoming one of the top 25 digital healthcare companies in the USA, and aims to break into the top 10 with the integration of Tevogen.AI [2]. - The proposed transaction is subject to due diligence, negotiation, execution of definitive documentation, required approvals, and customary closing conditions [2]. Group 2: Company Background - Tevogen is a healthcare enterprise focused on affordability, efficiency, and scientific rigor, leveraging AI and precision T cell therapy platforms to develop advanced therapies across multiple areas [4]. - Tevogen Bio has completed a proof-of-concept clinical trial for its T cell therapy, with a pipeline that includes virology, oncology, and neurology [5]. - Tevogen.AI aims to transform drug development by improving target detection and clinical trial design through predictive technologies [6]. Group 3: Future Initiatives - Tevogen is exploring additional strategic initiatives in life sciences, including domestic generics, biosimilars, medical devices, and innovative insurance solutions [3][7].

Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading energy and digital infrastructure company, today announced its preliminary, unaudited fourth quarter and fiscal year 2025 financial results in a letter to shareholders. Investors are invited to access the fourth quarter 2025 shareholder letter at MARA’s website at ir.mara.com. A copy of the letter will also be furnished to the Securities and Exchange Commission on a Form 8-K. MARA will hold a ...

This strategic integration empowers AWS customers to move beyond visibility and take control, providing a unified platform to discover, purchase, and govern every identity at the heart of their cloud security strategyAUSTIN, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise security today announced that SailPoint Identity Security Accelerator is now integrated with the Extended plan in AWS Security Hub, Amazon Web Services’ unified security solution. This integr ...

Significant Revenue Growth Delivers Higher than Expected Full-Year Net-Income and Adjusted EBITDA that Beat Guidance 23% Annualized Improvement in Leverage Ratio, While Also Returning Over $185 Million to Shareholders Through Dividends and Strategic Share Repurchases 2026 Guidance Reflects Confidence in the Business's Stability and Cash Generation Through Commodity Cycles Celebrating Our 25th Anniversary Year with the Completion of our Milestone of Primary Listing on the NYSE, US Incorporation, and Filing ...

Announced positive topline results from TX45 Phase 1b acute hemodynamic clinical trial in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH-HFrEF”) in October 2025. Topline results showed TX45 was well tolerated and improved both left heart function and pulmonary hemodynamics in patients with Group 2 PH-HFrEFTX2100 advanced into Phase 1a healthy volunteer clinical trial, randomizing the first subject in February 2026, as a potential treatment for Hereditary He ...

BIRMINGHAM, Ala., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Diversified Energy Company (NYSE:DEC, LSE: DEC) (“Diversified” or “the Company”) is pleased to announce that the Board has declared an interim dividend of 29 cents per share in respect of 4Q25 for the three-month period ended December 31, 2025. Key dates related to this dividend include: Record Date: May 29, 2026 Payment Date: June 30, 2026 Default Currency: US Dollar Currency Election Option: Sterling Last Date for Currency Election: June 5, 2026 ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- FTAI Infrastructure Inc. (NASDAQ:FIP) (the “Company” or “FTAI Infrastructure”) today reported financial results for the fourth quarter and full year 2025. The Company’s consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release. Business Highlights Reported $232.3 million(1) of Adjusted EBITDA for fiscal 2025, up 82% from fiscal 2024.Fourth quarter Adjusted EBITDA of $80.2 million(2) represented a ru ...